Get the free Form FDA 1571 - Investigational New Drug Application

Get Form

We are not affiliated with any brand or entity on this form

Fill out

Complete the form online in a simple drag-and-drop editor.

eSign

Add your legally binding signature or send the form for signing.

Share

Share the form via a link, letting anyone fill it out from any device.

Export

Download, print, email, or move the form to your cloud storage.

Why pdfFiller is the best tool for your documents and forms

Learn more about security

End-to-end document management

From editing and signing to collaboration and tracking, pdfFiller has everything you need to get your documents done quickly and efficiently.

Accessible from anywhere

pdfFiller is fully cloud-based. This means you can edit, sign, and share documents from anywhere using your computer, smartphone, or tablet.

Secure and compliant

pdfFiller lets you securely manage documents following global laws like ESIGN, CCPA, and GDPR. It's also HIPAA and SOC 2 compliant.

What is form fda 1571

The Form FDA 1571 is a Government document used by sponsors to submit an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA).

pdfFiller scores top ratings on review platforms

Show more Show less

Fill fillable fda 1571 form: Try Risk Free

Rate free fda 1571 form

4.0

satisfied

25 votes

Who needs form fda 1571?

Explore how professionals across industries use pdfFiller.

Form fda 1571 is needed by:

Pharmaceutical companies conducting clinical trials
Researchers seeking FDA approval for new drugs
Sponsors of clinical investigations, including individuals and organizations
Authorized representatives of sponsors needing to submit applications
Legal advisors assisting with IND submissions

Comprehensive Guide to form fda 1571

What is Form FDA 1571 - Investigational New Drug Application?

Form FDA 1571 serves as a crucial document for submitting an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA). This form signifies the initiation of a clinical investigation, playing a vital role in the drug development process. Regulatory compliance is a core component of the IND application process, ensuring safety and effectiveness in clinical trials.

The FDA oversees this process, assessing the submitted applications to determine whether the proposed clinical trials may proceed. The form must be filled out by sponsors, which include pharmaceutical companies or research organizations, at the outset of any investigational study. The use of Form FDA 1571 helps streamline the application process, ensuring that all pertinent details are evaluated.

Purpose and Benefits of Form FDA 1571

The primary purpose of Form FDA 1571 is to launch clinical investigations into new drugs. This document is essential for demonstrating regulatory compliance and maintaining participant safety throughout the study. By submitting this form, sponsors can substantially influence drug development timelines, minimizing the time from application to approval.

Furthermore, the submission of this FDA clinical trial form facilitates a structured approach to drug investigations, allowing regulatory bodies to monitor clinical developments effectively. It serves as a necessary step in adhering to industry regulations, which ultimately protects public health during the clinical trial phases.

Key Features of Form FDA 1571

Form FDA 1571 encompasses several key fields that must be accurately filled out. Key information includes the sponsor's details, drug specifications, and the phases of the clinical investigation. Each section is designed to collect comprehensive data while remaining user-friendly and accessible.

Sponsor information
Drug details
Clinical investigation phases
Signing requirements
Fillable nature of the document

It is important to note that the form requires signatures from the sponsor or their authorized representative, along with a countersignature if the signatory does not have a U.S. business presence.

Who Needs Form FDA 1571?

Form FDA 1571 is primarily needed by sponsors, which may include pharmaceutical companies, research organizations, and individual investigators. To fill out the IND submission form, the individuals involved must meet specific eligibility criteria and roles, such as:

Sponsor
Authorized representative
Countersigner for non-residents

These roles contribute to the completion and submission of the document, ensuring that all necessary parties are involved in the application process. Typical sponsors combine experience in clinical trials with a dedication to advancing medical science.

How to Fill Out Form FDA 1571 Online (Step-by-Step)

Completing Form FDA 1571 online involves several essential steps. First, gather necessary information, including the sponsor’s details and drug specifics. Then, follow the instructions for filling out the form:

Access the form through the designated platform.
Fill in the sponsor and drug information sections.
Provide details regarding the clinical investigation phases.
Review and verify all entries for accuracy.
Submit the form electronically through the suggested channels.

Each part of the form must be completed with precise information to ensure compliance and mitigate potential errors during submission.

Common Errors and How to Avoid Them

When filling out Form FDA 1571, users frequently encounter common mistakes that can derail the submission process. Potential errors include incomplete sections, inaccurate sponsor details, and failure to obtain necessary signatures. To ensure accuracy, consider these tips:

Double-check all entries before submission.
Ensure all required signatures are obtained.
Review the form for any missed fields.

Paying attention to the accuracy of the information submitted on the IND application form helps prevent delays and regulatory complications.

Signature Requirements for Form FDA 1571

Signature requirements for Form FDA 1571 stipulate the need for a sponsor's signature, which can be executed via digital means or traditional wet signatures. A countersigning requirement applies to non-U.S. residents who must have their signatures verified by a designated representative. To ensure proper execution, consider the following:

Use a secure eSigning method, like pdfFiller.
Confirm that all signers understand their signing roles.
Follow any additional state or federal guidelines on signatures.

Securing signatures is essential to validate the form and comply with regulatory standards.

Submission and Delivery Methods for Form FDA 1571

The submission process for Form FDA 1571 involves several methods that can vary based on the nature of the submission. Once the form is completed, it can be submitted via the following options:

Mail to the FDA’s designated office.
Electronic submission when available.

Be aware that certain fees may apply, and processing times can fluctuate depending on the method chosen. It is advisable to check directly with the FDA for the most current submission guidelines.

Security and Compliance When Using Form FDA 1571

When utilizing Form FDA 1571, security and compliance are paramount, especially since the form often contains sensitive information. pdfFiller employs robust security measures, including 256-bit encryption, to protect data as it is being processed.

Moreover, compliance with regulations such as HIPAA and GDPR ensures that all submitted information is handled securely and responsibly. A strong emphasis on data protection is critical for maintaining the integrity of the application process.

Unlock the Convenience of pdfFiller for Form FDA 1571

Using pdfFiller streamlines the process of creating, filling, and submitting Form FDA 1571. Users can take advantage of features such as cloud storage, eSigning capabilities, and editing tools to enhance their overall experience.

The platform prioritizes user convenience and efficiency, making it easier for sponsors to manage their applications. Emphasizing ease of use contributes to a seamless application process, ensuring that all forms are completed and submitted correctly.

Last updated on Apr 10, 2026

How to fill out the form fda 1571

1.

Start by accessing pdfFiller and searching for Form FDA 1571 in the template library.
2.

Once you find the form, click on it to open it within the pdfFiller interface.
3.

Review the form's fields and gather all necessary information about the sponsor and the investigational drug beforehand.
4.

Begin filling out the form, starting with the NAME OF SPONSOR in Field 1, ensuring that all details are accurate and complete.
5.

Move through each section methodically, using checkboxes and fillable fields to provide information about the investigation phases and required details.
6.

Pay special attention to signature requirements; ensure that either the sponsor or the authorized representative is prepared to sign the form.
7.

Once all fields are filled, review the form carefully to ensure compliance with all instructions provided.
8.

After confirming everything is accurate, save your progress and consider downloading a copy for your records.
9.

If ready, you can submit the form directly from pdfFiller or follow any additional instructions for submission via mail or online as necessary.

FAQs

If you can't find what you're looking for, please contact us anytime!

Contact Support

Who is eligible to use Form FDA 1571?

Form FDA 1571 is designed for sponsors of investigational new drug applications, including pharmaceutical companies, research organizations, and individual researchers seeking FDA approval for their drug trials.

What is the process for submitting Form FDA 1571?

Form FDA 1571 can be submitted electronically via pdfFiller or through traditional mail. A valid signature from the sponsor or an authorized representative is required on the form before submission.

Are there specific deadlines for submitting this form?

While there is no strict deadline for submitting Form FDA 1571, it is important to submit it before starting any clinical study to ensure regulatory compliance and timely review by the FDA.

What information is required to fill out Form FDA 1571?

Necessary information includes the sponsor's details, the drug being investigated, the phases of clinical investigation, and other relevant details regarding the study's design and purpose.

What common mistakes should I avoid when filling out this form?

Common mistakes include leaving fields blank, incorrect signatures, and providing incomplete or inaccurate details about the study or sponsor. Double-check all sections before submission.

Is notarization required for Form FDA 1571?

No, notarization is not required for Form FDA 1571. However, signatures must be from authorized individuals as specified in the instructions.

What are the typical processing times after submission?

Processing times for Form FDA 1571 can vary, but sponsors can expect a response from the FDA usually within 30 days, depending on the complexity of the application.